QS should be available for women in the United States.
Reason for the survey: To gather evidence to gain FDA approval for QS permanent contraception for women a safe and 98% effective method.
Why should I take this survey: To help U.S. women who wish to have no more children end their fertility without surgery.
How long will this survey take: Approximately 15 minutes.
How will I be compensated: Please specify and/or 501(C)3 nonprofit ISAF will email you a letter thanking you for your donation.
Background:
Watch a video (use the back button to return) and read about this safe and 98% effective non-drug in-office method.
The QS procedure – is a nonsurgical permanent contraceptive method for women. Using an intrauterine device (IUD) inserter a trained healthcare provider puts 7 tiny (36mg) quinacrine pellets into the uterus without need for general anesthesia twice. The 1st dose is given after a period ends. The 2nd dose is given one month later. The patient can return to work after each 15-minute visit and must keep using their old birth control method for the next 3 months while an immune response to the quinacrine pellets permanently blocks both fallopian tubes 98% of the time (not 99% like having your tubes tied). Blockage can be verified by ultrasound. This method is safe and has been used by more than 200,000 women in over 50 countries with minimal side effects lasting a day or less. Our book of clinical trials on Amazon and free here shows:
- QS is safer than surgical tubal ligation.
- QS is as safe and effective as an intrauterine device (IUD).
- We’ve conducted 2 successful FDA Phase 1 trials and published scores of peer reviewed papers.
- FDA halted our QS Phase 3 trial in 2006 based on a study which killed 1/3 of the rats after giving them 60 to 83 times the dose women receive.
- Criteria to resume the trial was met in 2016 but FDA still to this day refuses to permit the trial.
- We proved that QS causes no more long-term risk of reproductive cancer than an IUD.
- We proved that QS causes no more long-term risk of hysterectomy or ectopic pregnancy than an IUD.
- QS causes no cancer in rats given less than 8 times the dosage given to women.
- QS causes no cancer in mice given less than 12 times the dosage given to women.
- Quinacrine’s Integrated Signature of Carcinogenicity (ISC) is less than the ISC of caffeine.
- Millions of adults took the oral dosage of quinacrine weekly, equal to the QS dosage, with no cancer.